All Stories

  1. In-depth phenotypic characterization of reticulocyte maturation using mass cytometry
  2. Infection of mosquitoes from in vitro cultivated Plasmodium knowlesi H strain
  3. Plasmodium male gametocyte development and transmission are critically regulated by general and transmission-specific members of the CAF1/CCR4/NOT complex
  4. Persistence of Long-lived Memory B Cells specific to Duffy Binding Protein in individuals exposed to Plasmodium vivax
  5. Immunization efficacy of cryopreserved genetically attenuated Plasmodium berghei sporozoites
  6. A comprehensive model for assessment of liver stage therapies targeting Plasmodium vivax and Plasmodium falciparum
  7. Identification and Immunological Characterization of the Ligand Domain of Plasmodium vivax Reticulocyte Binding Protein 1a
  8. Uncovering the essential genes of the human malaria parasitePlasmodium falciparumby saturation mutagenesis
  9. Advancing Research Models and Technologies to Overcome Biological Barriers to Plasmodium vivax Control
  10. Lysophosphatidylcholine Regulates Sexual Stage Differentiation in the Human Malaria Parasite Plasmodium falciparum
  11. malERA: An updated research agenda for basic science and enabling technologies in malaria elimination and eradication
  12. An engineered vaccine of the Plasmodium vivax Duffy binding protein enhances induction of broadly neutralizing antibodies
  13. Experimental evaluation of cryopreservative solutions to maintain in vitro and in vivo infectivity of P. berghei sporozoites
  14. The Biology of Plasmodium vivax
  15. The development of sexual stage malaria gametocytes in a Wave Bioreactor
  16. Phenotypic Screens Identify Parasite Genetic Factors Associated with Malarial Fever Response in Plasmodium falciparumpiggyBac Mutants
  17. A simple and efficient method for cryopreservation and recovery of viable Plasmodium vivax and P. falciparum sporozoites
  18. The role of the human Duffy antigen receptor for chemokines in malaria susceptibility: current opinions and future treatment prospects
  19. Breadth of humoral response and antigenic targets of sporozoite-inhibitory antibodies associated with sterile protection induced by controlled human malaria infection
  20. Broadly neutralizing epitopes in the Plasmodium vivax vaccine candidate Duffy Binding Protein
  21. Chemogenomic profiling of Plasmodium falciparum as a tool to aid antimalarial drug discovery
  22. Improvement of culture conditions for long-term in vitro culture of Plasmodium vivax
  23. Retraction for Siddiqui et al., Fine Specificity of Plasmodium vivax Duffy Binding Protein Binding Engagement of the Duffy Antigen on Human Erythrocytes
  24. Enhancing longevity of Plasmodium vivax and P. falciparum sporozoites after dissection from mosquito salivary glands
  25. Plasmodium vivax Liver Stage Development and Hypnozoite Persistence in Human Liver-Chimeric Mice
  26. Plasmodium vivax Liver Stage Development and Hypnozoite Persistence in Human Liver-Chimeric Mice
  27. Structural Analysis of the Synthetic Duffy Binding Protein (DBP) Antigen DEKnull Relevant for Plasmodium vivax Malaria Vaccine Design
  28. The association of Duffy binding protein region II polymorphisms and its antigenicity in Plasmodium vivax isolates from Thailand
  29. Immunogenicity of a Synthetic Vaccine Based on Plasmodium vivax Duffy Binding Protein Region II
  30. Microphysical space of a liver sinusoid device enables simplified long-term maintenance of chimeric mouse-expanded human hepatocytes
  31. In silicoCharacterization of an Atypical MAPK Phosphatase ofPlasmodium falciparumas a Suitable Target for Drug Discovery
  32. Duffy Antigen Receptor for Chemokine (DARC) Polymorphisms and Its Involvement in Acquisition of Inhibitory Anti-Duffy Binding Protein II (DBPII) Immunity
  33. A rapid sensitive, flow cytometry-based method for the detection of Plasmodium vivax-infected blood cells
  34. Immunogenicity of single versus mixed allele vaccines of Plasmodium vivax Duffy binding protein region II
  35. Atypical Mitogen-Activated Protein Kinase Phosphatase Implicated in Regulating Transition from Pre-S-Phase Asexual Intraerythrocytic Development of Plasmodium falciparum
  36. Production of recombinant 1-deoxy-d -xylulose-5-phosphate synthase from Plasmodium vivax in Escherichia coli
  37. Finding the sweet spots of inhibition: Understanding the targets of a functional antibody against Plasmodium vivax Duffy binding protein
  38. Functional Analysis of Plasmodium vivax Dihydrofolate Reductase-Thymidylate Synthase Genes through Stable Transformation of Plasmodium falciparum
  39. Fine Specificity of Plasmodium vivax Duffy Binding Protein Binding Engagement of the Duffy Antigen on Human Erythrocytes
  40. Characterization of Inhibitory Anti-Duffy Binding Protein II Immunity: Approach to Plasmodium vivax Vaccine Development in Thailand
  41. Conserved and Variant Epitopes of Plasmodium vivax Duffy Binding Protein as Targets of Inhibitory Monoclonal Antibodies
  42. Fy a /Fy b antigen polymorphism in human erythrocyte Duffy antigen affects susceptibility to Plasmodium vivax malaria
  43. Design and Immunogenicity of a Novel Synthetic Antigen Based on the Ligand Domain of the Plasmodium vivax Duffy Binding Protein
  44. CCR4-Associated Factor 1 Coordinates the Expression of Plasmodium falciparum Egress and Invasion Proteins
  45. A reliable ex vivo invasion assay of human reticulocytes by Plasmodium vivax
  46. Why Is Plasmodium vivax a Neglected Tropical Disease?
  47. Determination of the Molecular Basis for a Limited Dimorphism, N417K, in the Plasmodium vivax Duffy-Binding Protein
  48. Development of the piggyBac transposable system for Plasmodium berghei and its application for random mutagenesis in malaria parasites
  49. A Genetic Screen for Attenuated Growth Identifies Genes Crucial for Intraerythrocytic Development of Plasmodium falciparum
  50. Acquired Antibody Responses against Plasmodium vivax Infection Vary with Host Genotype for Duffy Antigen Receptor for Chemokines (DARC)
  51. Defining the Role of Mutations in Plasmodium vivax Dihydrofolate Reductase-Thymidylate Synthase Gene Using an Episomal Plasmodium falciparum Transfection System
  52. Plasmodium vivax DBP Binding to Aotus nancymaae Erythrocytes Is Duffy Antigen Dependent
  53. Mapping Epitopes of the Plasmodium vivax Duffy Binding Protein with Naturally Acquired Inhibitory Antibodies
  54. Naturally acquired inhibitory antibodies toPlasmodium vivaxDuffy binding protein are short-lived and allele-specific following a single malaria infection
  55. A comprehensive Plasmodium falciparum protein interaction map reveals a distinct architecture of a core interactome
  56. piggyBac is an effective tool for functional analysis of the Plasmodium falciparum genome
  57. Identification of the transcription initiation site reveals a novel transcript structure for Plasmodium falciparum maebl
  58. Comparative genomics of the neglected human malaria parasite Plasmodium vivax
  59. An Erythrocyte Vesicle Protein Exported by the Malaria Parasite Promotes Tubovesicular Lipid Import from the Host Cell Surface
  60. The Malaria Secretome: From Algorithms to Essential Function in Blood Stage Infection
  61. The Transmembrane Isoform of Plasmodium falciparum MAEBL Is Essential for the Invasion of Anopheles Salivary Glands
  62. Inhibitory Properties of the Antibody Response to Plasmodium vivax Duffy Binding Protein in an Area with Unstable Malaria Transmission
  63. A highly sensitive, PCR-based method for the detection of Plasmodium falciparum clones in microtiter plates
  64. Plasmodium vivax Invasion of Human Erythrocytes Inhibited by Antibodies Directed against the Duffy Binding Protein
  65. Maurer's clefts of Plasmodium falciparum are secretory organelles that concentrate virulence protein reporters for delivery to the host erythrocyte
  66. Advancements in transfection technologies for Plasmodium
  67. Functional genomics of Plasmodium falciparum through transposon-mediated mutagenesis
  68. Interplasmid transposition demonstrates piggyBac mobility in vertebrate species
  69. The crystal structure of P. knowlesi DBPα DBL domain and its implications for immune evasion
  70. The structure of the Plasmodium falciparum EBA175 ligand domain and the molecular basis of host specificity
  71. High-efficiency transformation of Plasmodium falciparum by the lepidopteran transposable element piggyBac
  72. Apical expression of three RhopH1/Clag proteins as components of the Plasmodium falciparum RhopH complex
  73. Targeted disruption of maebl in Plasmodium falciparum
  74. Antigenic Drift in the Ligand Domain ofPlasmodium vivaxDuffy Binding Protein Confers Resistance to Inhibitory Antibodies
  75. Conserved residues in the Plasmodium vivax Duffy-binding protein ligand domain are critical for erythrocyte receptor recognition
  76. Conservation and Developmental Control of Alternative Splicing in maebl Among Malaria Parasites
  77. Antibodies against MAEBL Ligand Domains M1 and M2 Inhibit Sporozoite Development In Vitro
  78. Measurement of Antibody Levels against Region II of the Erythrocyte-Binding Antigen 175 of Plasmodium falciparum in an Area of Malaria Holoendemicity in Western Kenya
  79. Analysis of thePlasmodiumandAnophelesTranscriptomes during Oocyst Differentiation
  80. Epitope-Specific Humoral Immunity to Plasmodium vivax Duffy Binding Protein
  81. Fluorescent chloramphenicol as a substitute for radioactive [14C]-chloramphenicol for CAT reporter assays in Plasmodium falciparum
  82. Age‐Acquired Immunity to aPlasmodium vivaxInvasion Ligand, the Duffy Binding Protein
  83. Plasmodium falciparum MAEBL is a unique member of the ebl family
  84. Exploring the transcriptome of the malaria sporozoite stage
  85. An expanding ebl family of Plasmodium falciparum
  86. Duffy-null promoter heterozygosity reduces DARC expression and abrogates adhesion of theP. vivaxligand required for blood-stage infection
  87. Conserved regions of the Plasmodium yoelii rhoptry protein RhopH3 revealed by comparison with the P. falciparum homologue
  88. The erythrocyte binding motif of Plasmodium vivax Duffy binding protein is highly polymorphic and functionally conserved in isolates from Papua New Guinea
  89. Naturally Acquired and Vaccine-Elicited Antibodies Block Erythrocyte Cytoadherence of the Plasmodium vivaxDuffy Binding Protein
  90. Spatial and temporal dynamics of the secretory pathway during differentiation of the Plasmodium yoelii schizont
  91. Plasmodium yoelii YM MAEBL protein is coexpressed and colocalizes with rhoptry proteins
  92. A family of chimeric erythrocyte binding proteins of malaria parasites
  93. Erythrocyte binding protein homologues of rodent malaria parasites1Note: Nucleotide sequence data reported in this paper are available in the Genbank™ database under the accession numbers U78479, U78480, U78481, U78482, U78483.1
  94. Plasmodium vivax:Favored Gene Frequencies of the Merozoite Surface Protein-1 and the Multiplicity of Infection in a Malaria Endemic Region
  95. Dimorphism and intergenic recombination within the microneme protein (MP-1) gene family of Plasmodium knowlesi
  96. Identification of a cryptic intron in the Plasmodium vivax Duffy binding protein gene
  97. A family of erythrocyte binding proteins of malaria parasites.
  98. Cloning of the Plasmodium vivax Duffy receptor
  99. The duffy receptor family of plasmodium knowlesi is located within the micronemes of invasive malaria merozoites